Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
Condition: Endocarditis Infective Interventions: Drug: Cefaclor; Drug: Ciprofloxacin Tablets; Drug: Ciprofloxacin Injection; Drug: Clindamycin Oral Capsule; Drug: Clindamycin Injection; Drug: Dicloxacillin Oral Capsule; Drug: Dicloxacillin; Drug: Fusidic Acid Only Product in Oral Dose Form; Drug: F usidic Acid Only Product in Parenteral Dose Form; Drug: Levofloxacin Oral Tablet; Drug: Levofloxacin Injection; Drug: Linezolid Oral Tablet; Drug: Linezolid Injectable Product; Drug: Moxifloxacin tablet; Drug: Moxifloxacin Injectable Product; Drug: Rifampicin O nly Product in Oral Dose Form; Drug: Rifampicin Only Product in Parenteral Dose Form; Drug: Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim]; Drug: Sulfamethoxazole / Trimethoprim Injectable Product; Drug: Tedizolid Oral Tablet; Drug: Tedizolid Injection; Drug: Amox icillin Capsules; Drug: Amoxicillin; Drug: Cefaclor Capsules Sponsor: Fundacion Clinic per a la Recerca Biomédica Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Amoxicillin | Bactrim | Endocarditis | Infective Endocarditis | Research | Sulfamethoxazole | Trimethoprim